ARTMS

In May 2020, ARTMS announced a Series A round financing of $19 million. ARTMS develops and commercializes diagnostic imaging isotopes, utilizing hospital and other medical cyclotrons. The Company’s technology enables cost-effective, decentralized, and local production of medical isotopes.